Articles by Tim Burroughs
KKR agrees China pharmacy acquisition
KKR has agreed to acquire a majority stake in Chinese pharmacy chain Ruirentang Pharmaceutical Group, according to a filing by a local regulator.
Carlyle, Trustar pursue partial exit, rollover of McDonald's China
The Carlyle Group and Trustar Capital, private equity owners of McDonald’s China, are poised to abandon plans for a single asset continuation fund in favour of exiting part of their holdings and rolling over the rest into other funds.
China's GTA Semiconductor raises $1.85b
GTA Semiconductor, a China-based semiconductor foundry specialising in chips for the automotive industry, has raised CNY 13.5bn (USD 1.85bn) in funding from unnamed investors.
Australia's The Growth Fund expected to disband
The Growth Fund, an Australian mid-market private equity (PE) firm, is expected to manage out its current portfolio and then disband
500 Global raises $143m for Southeast Asia
500 Global has raised USD 100m for its third Southeast Asia-focused early-stage fund and USD 43m for a vehicle that will target growth-stage start-ups in the region.
CP Group, LDA Capital launch $2b Southeast Asia fund
Thailand-based conglomerate Charoen Pokphand Group (CP Group) has launched a USD 2bn fund that will focus on high-growth middle-market companies in Southeast Asia.
CVC expands into infrastructure with DIF acquisition
CVC Capital Partners has expanded into the infrastructure space with the acquisition of DIF Capital Partners, a Netherlands-headquartered manager with an investment footprint that includes Australia.
Deal focus: Patience pays off for Trustar on Moritex
Trustar Capital’s 20x return on Japanese precision manufacturing business Moritex was driven by greater geographic diversification in production and distribution and a shakeup of the product portfolio
Indonesia VC: Institutional upgrade?
Having won early support from as assortment of local conglomerates, Indonesian venture capital firms must now demonstrate their independence when pitching international LPs
Japan Industrial Partners sets $2bn hard cap for Fund VI
Japan Industrial Partners (JIP), the Japanese private equity firm leading the USD 15bn privatisation of Toshiba, has set the hard cap for its latest fund at JPY 300bn (USD 2bn) and secured a six-month extension to the fundraising period.
Australia’s Anacacia targets up to $290m for Fund IV
Australian middle market private equity firm Anacacia Capital is preparing to launch its fourth fund, telling investors that it expects to surpass the AUD 300m (USD 193m) raised for Fund III but would not exceed AUD 450m.
China's TH Capital hits first close on debut US dollar fund
TH Capital, a private equity firm that originated from China's Tsinghua University and was formerly known as Tsinghua Holdings Capital, has completed a USD 60m first close on its debut US dollar-denominated fund.
Japanese autonomous trucking start-up raises $24m
T2, a Japanese autonomous driving start-up that focuses on trucking, has raised JPY 3.5bn (USD 24.1m) in Series A funding from a combination of financial and strategic investors.
PEP to buy Australia's Healthia for $168m
Pacific Equity Partners (PEP) has agreed to acquire Healthia, an Australia-based healthcare services provider specialising in physiotherapy, podiatry, and optometry, for an equity value of AUD 260m (USD 168m).
Templewater buys Singapore precision engineering player
Templewater, a Hong Kong-headquartered investment firm that spun out from Investec Group’s principal investments division, has acquired Singapore-based precision engineering business Knight Auto Precision Engineering.
Longreach buys Japanese assisted stretching business
The Longreach Group has acquired Nobitel, a Japanese company that provides one-on-one assisted stretching services aimed in part at the country’s ageing population, for an undisclosed sum.
China carpooling player Dida revives Hong Kong IPO bid
Dida, a PE-backed Chinese car-pooling and ride-hailing platform, has filed to list in Hong Kong – for the fourth time in three years. There are records of lapsed registrations from 2020, 2021, and earlier in 2023.
China EV maker Hozon raises $961m in crossover funding
Hozon Auto, a Chinese electric vehicle (EV) manufacturer, has raised CNY 7bn (USD 961m) in crossover or pre-IPO funding from unnamed investors.
Deal focus: Family offices flock to FirstCry
FirstCry’s USD 52m funding round underscores the willingness of certain Indian family offices to lead sizeable technology deals and the importance attached by companies to investor base diversification
China secondaries: Willing sellers?
Few, if any, LPs are so desperate to divest China exposure that they will sell fund positions at any price. The main sticking point for secondary transactions is a disconnect on valuations
China's HC Scientific gets $41m Series B extension
Lake Bleu Capital and Guotai Junan Innovation Investment have led a Series B extension of approximately CNY 300m (USD 41m) for HC Scientific, a manufacturer of DNA sequencing devices used in modern agriculture and healthcare.
China's PE-backed Ubtech Robotics files for HK IPO
Ubtech Robotics, a China-based developer of service and humanoid robots valued at CNY 32bn (USD 4.4bn) in its most recent private funding round, has filed for a Hong Kong IPO.
Indonesia's Venturra teams up with Dasym for next fundraise
Indonesian venture capital firm Venturra has teamed up with Netherlands-based investment group Dasym to institutionalise operations ahead of the launch of its next fund.
JIP supports Japan cancer diagnostics joint venture
Japanese private equity firm Japan Industrial Partners (JIP) is participating in a local joint venture with BostonGene, a US-based provider of artificial intelligence-enabled (AI) profiling solutions used to treat cancer patients.